BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

January to March 2008

OXFORD BIOMEDICA REPORT ENCOURAGING NEW PHASE II TRIAL RESULTS WITH TROVAX IN PROSTATE CANCER

Lab21 acquires NPTech Ltd and appoints corporate advisors for European M&A activity

BAC signs license agreement with Hematech

Agilent Technologies Makes Powerful GC, GC/MS Capabilities Accessible to Wider Range of Labs

Agilent Technologies Debuts Acquisitions, Significant Workflow Innovations at Pittcon

Agilent Technologies Hosts China Anti-Doping Agency Officials

GE HEALTHCARE INTRODUCES NANOVUET - FAST AND EASY-TO-USE SPECTROPHOTOMETER

Synoptics Group acquired by Scientific Digital Imaging Ensuring Synoptics will Retain its Leading Position in Life Science Imaging

Hybrigenics: 2007 Revenues, Significant Progress in Cancer-related R&D Programmes

Mapreg Granted Orphan Status in Europe for its Lead Drug Candidate Under Development for Treatment of Spinal Cord Injury

Simcyp Limited appoints Professor Carl Peck to its Scientific Advisory Board

PREDICTIVE GENETIC TEST FOR BOWEL CANCER TREATMENT IS INTRODUCED IN THE UK

Cobra Biomanufacturing Plc receives approval for research and development tax credit from the French Ministry for Higher Education and Research

BAC and Octapharma to develop custom ligand for recombinant plasma protein

European biotech industry sets the record straight on biofuels and outlines contribution of biotech to a low-carbon society

New Books on Best Practices in Biotechnology Business Development and Biotechnology Education

BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies

PRONOSTICS signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe’s largest diagnostics market

Cyclacel Pharmaceuticals announces financial results for Fourth Quarter and Year Ended December 31, 2007

TTP LabTech Announce Licensing of Acoustic Technology for Label-free Interaction Analysis

Nimbus changes name to Sovicell and launches new website

GATC Biotech opens new subsidiary in Stockholm, Sweden

Upfront Chromatography Appoints VP Sales and Marketing - Søren Pedersen to lead worldwide sales and marketing of RhobustTM

OXFORD BIOMEDICA APPOINTS DR ALEX LEWIS AS NON-EXECUTIVE DIRECTOR

OXFORD BIOMEDICA COMPLETES PATIENT RECRUITMENT FOR PHASE III TRIST STUDY OF TROVAX IN RENAL CANCER

OXFORD BIOMEDICA PLC: PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2007

Glide Pharma signs biologicals deal with major pharma company

Take the Astech Automation Challenge at Interphex 2008

Biocitech Celebrates its 5th Anniversary with an Occupancy Rate in Excess of 80 Percent

Olympus adds Advanced Optigrid M Illumination System to Life Science Microscopy Range

BTG Initiates Clinical Study of Novel Multiple Sclerosis Treatment

Cyclacel Pharmaceuticals (NASDAQ:CYCC) to announce fourth quarter 2007 financial results on 11March 2008

PanGenetics raises 23 million Euro in a series C financing to fund clinical advancement of its therapeutic antibody programs

Forbion Capital Partners co-invests in €23M

Cyclacel's David Glover to present at New York of Sciences Symposium

Drug Patent Expirations in March 2008

Novel, fully integrated Sample Dispersion Unit is key to Morphologi G3 particle characterization speed and repeatability

GE broadens multi-vendor asset management portfolio

Trophos SA Awarded USD 1.4 Million to Develop Promising Compounds in Preclinical Models of Ischemia-reperfusion Injury

Cobra enters into manufacturing agreement to produce SARS protein in CHO cells

ABLYNX ANNOUNCES FULL YEAR RESULTS FOR 2007

A simple blood test can now be used to help identify a wide range of diseases

Index Ventures invests US$80M in Adconion Media group

ReachBio Partners with Axiogenesis to Distribute Novel Cell-Based Products in North America

67% OF FARMERS ARE READY TO GROW GMOS IMMEDIATELY SAYS A DEMOSKOPEA SURVEY

Scottish biotech consortium to create new generation of drug tests

PANalytical at PITTCON 2008 New products and new applications in New Orleans

Dymension 2D Gel Analysis Software used at Specialist Institute To Identify Proteins Induced by an Anti-Addictive Compound

Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients

ERBI announces a spectacular speaker line-up for its 10th Anniversary BioPartnering Exchange Conference

Agilent Technologies Microarrays Enable Baylor Researchers to Discover a Mechanism of Genomic “Errors” Associated with Certain Diseases

Agilent Technologies Microarrays Play Role in Researchers’ Study of Autism’s Relationship to Extra or Missing Genes

Agilent Technologies Introduces High-Sensitivity Protein Kit for its Bioanalyzer that Outperforms Silver-Stained Gels

Agilent Technologies Introduces First Gene Expression Bioinformatics System Offering Guided Workflows

Agilent's Oligo Library Synthesis Technology Used To Capture Sequencing Targets from Genomic DNA

Global biopharmaceutical leader UCB selects IDBS’ BioBook for DMPK and Pharmacology

Affimed Increases Series B Financing in Second Closing to Euro 30 Million (USD 45 Million)

OXFORD BIOMEDICA ANNOUNCES DATA SAFETY MONITORING BOARD RECOMMENDATION TO CONTINUE TROVAX PHASE III TRIST STUDY OF TROVAX

Acrux (ASX:ACR) reports compelling results of market research on Testosterone MD-Lotion

Mbiotech to distribute Gene Bridges Recombineering Technology in Korea

Cobra Announces Prize for Presentation on its Rapid Mammalian Protein Expression Technology, UCOE

AM-Pharma announces appointment of new VP Clinical Development

First G:BOX HR Gel Documentation System Installed on Jurong Island Will Contribute to Major Research Programmes in Emerging Technology Hub

PG Economics welcomes new ISAAA brief: Global status of commercialised biotech GM crops 2007

Medical Solutions enters an exclusive UK agreement with Empire Genomics, LLC as a distributor and service provider for ACCUArray genotyping

Moths in Oxford Aid Drug Discovery

2008 is a decisive year for the validation of the asthma target interleukin-13

Biocitech Companies Scoop EUR 100 Million in January

Gastrotech completes $6 million Series D fundraising

Trophos SA Receives Grant from The Michael J. Fox Foundation to Evaluate Compounds in Parkinson's Disease Model

Illumina Sequences the First African Human Genome

Medical Solutions becomes first UK commercial service provider of Illumina next generation DNA sequencing and genotyping applications

Diabetes, Growth Disorders Drive Sales of Pediatric Hormone Drugs

Astex Receives IND Approval for its Small Molecule HSP90 Inhibitor AT13387

New Technology Combinations and Innovations to Propel Cell-Based Diagnostic Market to Nearly $9 Billion by 2011

More Competitors and Compatibility Opens Up Multi-Billion-Dollar Gene Expression Analysis Market

Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine

mtm laboratories launches CervatecT Assay for cervical cancer screening

First time at Analytica for Malvern’s Morphologi G3

OSLO BIO UPDATE - NEWSLETTER FEBRUARY 2008 - the life science cluster in the Oslo region

Mole Genetics launch first "personal" automated DNA purification system for under Euros 10,000

Midatech secures exclusive position to exploit magnetic noble metal nanoparticles through new IP licenses

Drug Patent Expirations in February 2008

RICERCA BIOSCIENCES, LLC APPOINTS R. IAN LENNOX Chief Executive officer

Polyplus-transfection has produced the first GMP-quality clinical batch of its nucleic acid transfer agent

New Microbiology Imaging Software Offers Fast, Accurate Analysis of Colony Numbers and Zone Sizes

BTG plc commences first clinical study of novel migraine treatment

Alsace Biovalley(TM)" gives new boost to Alsace region life science and healthcare

ProtAffin AG appoints Dr. Simon Moroney to Supervisory Board

Gastrotech signs licensing agreement with Eli Lilly following positive clinical data on compound for Irritable Bowel Syndrome

COBRA ANNOUNCES MANUFACTURING AGREEMENT FOR TNFERADE

Quantum Genomics Corp Partners with Inserm in Stroke and Cardiac Ischemia Drug Development

Biotech industry supports Europe's Renewable Energy Directive and its sustainability criteria for biofuels

GE HEALTHCARE CUSTOMERS REALIZE BEAUTY OF SCIENCE AS RESEARCH TO BE PUBLISHED IN TIMES SQUARE

BTG plc: Interim Management Statement

Lab21 launches cancer gene testing service

ROBERT A. SCOTT, M.D., APPOINTED CHIEF MEDICAL OFFICER OF CERENIS THERAPEUTICS

Endotis Pharma Raises €25 million in a Second Financing Round led by the Wellcome Trust

Without Lifting the Lid: TTP LabTech Take Tube Volume Detection to the Next Level

Malvern launches ISys 5.0 – powerful chemical imaging analysis software for cross-platform analysis

Thermo Fisher Scientific Honored with Prestigious Market Leadership Award for High Content Screening Offering

OXFORD BIOMEDICA ANNOUNCES DEVELOPMENT MILESTONE IN ITS COLLABORATION WITH MOLMED

INDEX VENTURES ANNOUNCES €400 MILLION GROWTH FUND

Cobra Biomanufacturing appoints Chief Operating Officer

BioInvent and ThromboGenics Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer

PANalytical and CERN collaboration brings first commercial application of Medipix2

Malvern ® Instruments acquires Viscotek Corporation

More Competitors and Compatibility Opens Up Multi-Billion-Dollar Gene Expression Analysis Market

New Technology Combinations and Innovations to Propel Cell-Based Diagnostic Market to Nearly $9 Billion by 2011

PFIZER AND SCIL FINALIZE AGREEMENT FOR NOVEL CARTILAGE GROWTH FACTOR

Pantec Biosolutions presents new drug delivery platform at Drug Delivery Partnerships 2008

Molecular Partners AG collaborates with Centocor Research & Development, Inc.

Protagen raises €1 million to expand its protein biochips business unit

BioInvent and Genentech Initiate Phase I Clinical Trial for BI-204, a potential treatment for cardiovascular conditions associated with atherosclerosis.

Renowned scientist opens new PANalytical offices

GE HEALTHCARE PRESENTS NEW DATA MANAGEMENT SOLUTION FOR HIGH CONTENT ANALYSIS AND SCREENING

GE HEALTHCARE ANNOUNCES STRATEGIC PARTNERSHIPS WITH PROCESS ANALYSIS AND AUTOMATION AND MATRICAL TO EXTEND ITS HIGH CONTENT ANALYSIS OFFERINGS

French biotech crop decision environmentally unfriendly

A new, unique and unrivalled Rat Mouse PINP assay for Pharmaceutical, Clinical and Academic Research Organizations.

ProtAffin AG completes second closing of Series A financing

CEVEC again successful in challenge to Crucell patent

NOVACTA RECEIVES £3.5 MILLION STRATEGIC TRANSLATION AWARD FROM THE WELLCOME TRUST TO TARGET C.DIFFICILE INFECTIONS

ARTES and Minapharm sign long-term strategic development agreement

Major Veterinary Centre to Increase Throughput of Antibiotic Potency Testing By Installing Sixteen ProtoCOL Automated Inhibition Zone Sizing Systems

Thermo Fisher Scientific Launches New Stem Cell Solutions Program

New Olympus UIS2 objectives completes the ultimate ergonomic solution for cytology applications

Agilent Technologies Completes Acquisition of Velocity11, a Leader in Life Science Lab Automation and Robotics

Pharmaceutical Profiles seminar success

Illumina Introduces the InfiniumR High-Density (HD) Human1M-Duo and Human610-Quad BeadChips

Syngene Unveils First Multi-application Single Lighting Module For Rapidly Imaging Fluorescent Dyes with a G:BOX Chemi Image Analyser

Breaking Rules and Bucky Balls - Eminent list of plenary speakers announced for MICROSCIENCE 2008

Drug Patent Expirations in January 2008

Gene Bridges granted Korean Patent for Recombineering Technology

Biotech industry welcomes European Commission's communication on European Lead Market Initiative

NextGen Sciences Announces Commercial Alliance with Paragon Bioservices, Inc

OXFORD BIOMEDICA SECURES EXCLUSIVE LICENCE TO KEY INTELLECTUAL PROPERTY FOR RNA INTERFERENCE GENE SILENCING USING LENTIVECTOR TECHNOLOGY

Positive Phase I and pre-clinical data suggest Acambis’ M2e-based universal influenza vaccine, ACAM-FLU-A™

Astech Raise the Bar of Inhaler Testing


October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive


Site Map - new news site

Site Map - old news site

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.